首页> 外文期刊>Neurosurgical focus >Minimally invasive surgical treatment of intracranial meningiomas in elderly patients (≥ 65 years): outcomes, readmissions, and tumor control
【24h】

Minimally invasive surgical treatment of intracranial meningiomas in elderly patients (≥ 65 years): outcomes, readmissions, and tumor control

机译:老年患者颅内脑膜瘤的微创手术治疗(≥65岁):结果,再生和肿瘤控制

获取原文
           

摘要

OBJECTIVE Increased lifespan has led to more elderly patients being diagnosed with meningiomas. In this study, the authors sought to analyze and compare patients ≥ 65 years old with those 65 years old who underwent minimally invasive surgery for meningioma. To address surgical selection criteria, the authors also assessed a cohort of patients managed without surgery. METHODS In a retrospective analysis, consecutive patients with meningiomas who underwent minimally invasive (endonasal, supraorbital, minipterional, transfalcine, or retromastoid) and conventional surgical treatment approaches during the period from 2008 to 2019 were dichotomized into those ≥ 65 and those 65 years old to compare resection rates, endoscopy use, complications, and length of hospital stay (LOS). A comparator meningioma cohort of patients ≥ 65 years old who were observed without surgery during the period from 2015 to 2019 was also analyzed. RESULTS Of 291 patients (median age 60 years, 71.5% females, mean follow-up 36 months) undergoing meningioma resection, 118 (40.5%) were aged ≥ 65 years and underwent 126 surgeries, including 20% redo operations, as follows: age 65–69 years, 46 operations; 70–74 years, 40 operations; 75–79 years, 17 operations; and ≥ 80 years, 23 operations. During 2015–2019, of 98 patients referred for meningioma, 67 (68%) had surgery, 1 (1%) had radiosurgery, and 31 (32%) were observed. In the 11-year surgical cohort, comparing 173 patients 65 years versus 118 patients ≥ 65 years old, there were no significant differences in tumor location, size, or outcomes. Of 126 cases of surgery in 118 elderly patients, the approach was a minimally invasive approach to skull base meningioma (SBM) in 64 cases (51%) as follows: endonasal 18, supraorbital 28, minipterional 6, and retrosigmoid 12. Endoscope-assisted surgery was performed in 59.5% of patients. A conventional approach to SBM was performed in 15 cases (12%) (endoscope-assisted 13.3%), and convexity craniotomy for non–skull base meningioma (NSBM) in 47 cases (37%) (endoscope-assisted 17%). In these three cohorts (minimally invasive SBM, conventional SBM, and NSBM), the gross-total/near-total resection rates were 59.5%, 60%, and 91.5%, respectively, and an improved or stable Karnofsky Performance Status score occurred in 88.6%, 86.7%, and 87.2% of cases, respectively. For these 118 elderly patients, the median LOS was 3 days, and major complications occurred in 10 patients (8%) as follows: stroke 4%, vision decline 3%, systemic complications 0.7%, and wound infection or death 0. Eighty-three percent of patients were discharged home, and readmissions occurred in 5 patients (4%). Meningioma recurrence occurred in 4 patients (3%) and progression in 11 (9%). Multivariate regression analysis showed no significance of American Society of Anesthesiologists physical status score, comorbidities, or age subgroups on outcomes; patients aged ≥ 80 years showed a trend of longer hospitalization. CONCLUSIONS This analysis suggests that elderly patients with meningiomas, when carefully selected, generally have excellent surgical outcomes and tumor control. When applied appropriately, use of minimally invasive approaches and endoscopy may be helpful in achieving maximal safe resection, reducing complications, and promoting short hospitalizations. Notably, one-third of our elderly meningioma patients referred for possible surgery from 2015 to 2019 were managed nonoperatively.
机译:目标增加的寿命导致更多老年患者被诊断患有脑膜瘤。在这项研究中,作者试图分析和比较患者≥65岁,那些<65岁的人接受了脑膜瘤的微创手术。为了解决手术选择标准,作者还评估了在没有手术的情况下管理的患者队列。方法在回顾性分析中,在2008年至2019年期间接受了微创(内和缺水,微嘌呤,Transfalcine,或逆压)的连续脑膜瘤患者在2008年至2019年期间,分为那些≥65和65岁的人比较切除率,内窥镜检查,并发症和住院住宿时间(LOS)。还分析了2015年至2019年期间没有手术观察到的患者≥65岁的患者的比较脑膜瘤队≥65岁。结果291例(中位年龄60岁,71.5%,平均随访36个月)接受脑膜瘤切除,118岁(40.5%)龄≥65岁,并经过126名手术,其中包括20%的重做行动,如下:年龄65-69岁,46次运营; 70-74岁,40次操作; 75-79岁,17次运营;和≥80年,23个操作。在2015 - 2019年期间,98例脑膜瘤患者,67名(68%)进行手术,1(1%)具有放射肠外放射外科,观察到31(32%)。在11年的外科队列中,比较173名患者<65岁对118例≥65岁,肿瘤位置,大小或结果没有显着差异。在118名老年患者中的126例手术中,该方法是在64例(51%)中的头骨基础脑膜瘤(SBM)的微创方法,如下所示:内切糖18,超低28,微小6,和逆潮12.内窥镜辅助手术在59.5%的患者中进行。在47例(37%)(37%)(内窥镜辅助17%)中,在15例(12%)(内窥镜辅助13.3%)中进行常规方法(12%)(内窥镜辅助13.3%),凸性脑膜瘤(NSBM)(NSBM)(内窥镜辅助17%)。在这三个队列(微创SBM,常规SBM和NSBM)中,总共总/近总切除率分别为59.5%,60%和91.5%,并且发生了改进或稳定的Karnofsky性能状态分数分别为88.6%,86.7%和87.2%的病例。对于这118名老年患者,中位数LOS为3天,10名患者发生重症并发症(8%)如下:中风4%,视力下降3%,全身并发症0.7%,伤口感染或死亡0.8岁患者的三个患者被排出回家,5例患者发生了入伍(4%)。脑膜瘤复发发生在4名患者(3%)和11名(9%)中发生。多元回归分析表明,美国麻醉学家身体状况得分,合并症或年龄亚组对成果的重要性; ≥80岁的患者表现出较长的住院趋势。结论该分析表明,仔细选择的脑膜瘤患者通常具有优异的外科术后和肿瘤控制。当适当施用时,使用微创方法和内窥镜检查可能有助于实现最大安全切除,减少并发症和促进短期住院治疗。值得注意的是,2015年至2019年可能从2015年到2019年提到的三分之一的年长脑膜瘤患者是非手术的。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号